Effects of bisphenol A on the expression of cytochrome P450 aromatase (CYP19) in human fetal osteoblastic and granulosa cell-like cell lines

Toxicology Letters

Volumn 210, Issue 1, 2012, Pages 95-99

  Watanabe, Masatada ^a   Ohno, Shuji ^a   Nakajin, Shizuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Aromatase; Bisphenol A; Osteoblastic cells; Ovarian granulosa like cells

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AROMATASE;

ARTICLE; CELL LINE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AROMATASE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; FETUS; GENE EXPRESSION; GRANULOSA CELLS; HUMANS; OSTEOBLASTS; PHENOLS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84857227158     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.01.020     Document Type: Article

References (33)

1. Ahn S.W., Nedumaran B., Xie Y., Kim D.K., Kim Y.D., Choi H.S. Bisphenol A bis(2,3-dihydroxypropyl) ether (BADGE.2H2O) induces orphan nuclear receptor Nur77 gene expression and increases steroidogenesis in mouse testicular Leydig cells. Mol. Cells 2008, 26:74-80.
2. Alexiadis M., Eriksson N., Jamieson S., Davis M., Drummond A.E., Chu S., Clyne C.D., Muscat G.E., Fuller P.J. Nuclear receptor profiling of ovarian granulosa cell tumors. Horm. Cancer 2011, 2:157-169.
3. Alonso-Magdalena P., Laribi O., Ropero A.B., Fuentes E., Ripoll C., Soria B., Nadal A. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ. Health Perspect. 2005, 113:969-977.
4. Arts J., Kuiper G.G., Janssen J.M., Gustafsson J.A., Lowik C.W., Pols H.A., van Leeuwen J.P. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 1997, 138:5067-5070.
5. Chiba H., Sawada N., Ono T., Ishii S., Mori M. Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone. Jpn. J. Cancer Res. 1993, 84:290-297.
6. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Conner K., Zacharewski T., Safe S., McDonnell D.P., Gaido K.W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrinol. 1998, 142:203-214.
7. Heimeier R.A., Das B., Buchholz D.R., Shi Y.B. The xenoestrogen bisphenol A inhibits postembryonic vertebrate development by antagonizing gene regulation by thyroid hormone. Endocrinology 2009, 150:2964-2973.
8. Huang H., Leung L.K. Bisphenol A downregulates CYP19 transcription in JEG-3 cells. Toxicol. Lett. 2009, 189:248-252.
9. Iwakura T., Iwafuchi M., Muraoka D., Yokosuka M., Shiga T., Watanabe C., Ohtani-Kaneko R. In vitro effects of bisphenol A on developing hypothalamic neurons. Toxicology 2010, 272:52-58.
10. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
11. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
12. Melzer D., Rice N.E., Lewis C., Henley W.E., Galloway T.S. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010, 5:e8673.
13. Moriyama K., Tagami T., Akamizu T., Usui T., Saijo M., Kanamoto N., Hataya Y., Shimatsu A., Kuzuya H., Nakao K. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 2002, 87:5185-5190.
14. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 1997, 105:70-76.
15. Nativelle-Serpentini C., Richard S., Seralini G.E., Sourdaine P. Aromatase activity modulation by lindane and bisphenol-A in human placental JEG-3 and transfected kidney E293 cells. Toxicol In Vitro 2003, 17:413-422.
16. Nishi Y., Yanase T., Mu Y., Oba K., Ichino I., Saito M., Nomura M., Mukasa C., Okabe T., Goto K., Takayanagi R., Kashimura Y., Haji M., Nawata H. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 2001, 142:437-445.
17. Noda M., Ohno S., Nakajin S. Mono-(2-ethylhexyl) phthalate (MEHP) induces nuclear receptor 4A subfamily in NCI-H295R cells: a possible mechanism of aromatase suppression by MEHP. Mol. Cell. Endocrinol. 2007, 274:8-18.
18. Ohno S., Nakajin S. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab. Dispos. 2009, 37:32-40.
19. Ohno S., Yukinawa F., Noda M., Nakajin S. Mono-(2-ethylhexyl) phthalate induces NR4A subfamily and GIOT-1 gene expression, and suppresses CYP19 expression in human granulosa-like tumor cell line KGN. Toxicol. Lett. 2009, 191:353-359.
20. Prasanth G.K., Divya L.M., Sadasivan C. Bisphenol-A can bind to human glucocorticoid receptor as an agonist: an in silico study. J. Appl. Toxicol. 2010, 30:769-774.
21. Ramakrishnan S., Wayne N.L. Impact of bisphenol-A on early embryonic development and reproductive maturation. Reprod. Toxicol. 2008, 25:177-183.
22. Reinsberg J., Wegener-Toper P., van der Ven K., van der Ven H., Klingmueller D. Effect of mono-(2-ethylhexyl) phthalate on steroid production of human granulosa cells. Toxicol. Appl. Pharmacol. 2009, 239:116-123.
23. Rubin B.S. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J. Steroid Biochem. Mol. Biol. 2011, 127:27-34.
24. Rubin G.L., Zhao Y., Kalus A.M., Simpson E.R. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res. 2000, 60:1604-1608.
25. Santen R.J., Brodie H., Simpson E.R., Siiteri P.K., Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr. Rev. 2009, 30:343-375.
26. Shozu M., Simpson E.R. Aromatase expression of human osteoblast-like cells. Mol. Cell. Endocrinol. 1998, 139:117-129.
27. Song K.H., Lee K., Choi H.S. Endocrine disrupter bisphenol a induces orphan nuclear receptor Nur77 gene expression and steroidogenesis in mouse testicular Leydig cells. Endocrinology 2002, 143:2208-2215.
28. Sun T., Zhao Y., Mangelsdorf D.J., Simpson E.R. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells. Endocrinology 1998, 139:1684-1691.
29. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
30. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
31. Watanabe M., Nakajin S. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R. J. Endocrinol. 2004, 180:125-133.
32. Watanabe M., Simpson E.R., Pathirage N., Nakajin S., Clyne C.D. Aromatase expression in the human fetal osteoblastic cell line SV-HFO. J. Mol. Endocrinol. 2004, 32:533-545.
33. Ye L., Chan M.Y., Leung L.K. The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Mol. Cell. Endocrinol. 2009, 302:73-80.